Researchers at Massachusetts General Hospital (MGH) have identified a potential mechanism by which tobacco smoking drives a type of white blood cell known as monocytes to the lung where they can increase the risk of active ...
Dec 13, 2023
0
21
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has posed unprecedented challenges worldwide. While extensive efforts have focused on understanding the clinical features, diagnosis, and treatment of COVID-19, ...
Dec 12, 2023
0
21
Viruses have limited genetic material—and few proteins—so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins. Now, in a study published in the journal PLOS Pathogens, researchers ...
Dec 9, 2023
0
38
On good days, the immune system can effectively handle pathogens that invade the body. However, when foreign matter takes the upper hand, the body builds a wall of immune cells called granuloma around the pathogens to isolate ...
Dec 7, 2023
0
0
Around 320,000 new cases of leukemia, a type of blood cancer that can affect all population groups, are diagnosed every year in Europe. In children, cases of leukemia make up a third of diagnosed cancers. Chemotherapy is ...
Dec 7, 2023
0
0
The immune system can carry out many biological processes, from killing viruses to fighting cancer, thanks in large part to approximately 100 key cell-signaling proteins called cytokines, which instruct immune cells what ...
Dec 7, 2023
0
10
Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice. Silencing the galectin 1 (Gal1) protein, which is often ...
Nov 30, 2023
0
0
Researchers from The University of Queensland (UQ) have discovered a new way a ribonucleic acid (RNA) impacts fear-related learning and memory.
Nov 30, 2023
0
196
Insights that pave the way for novel therapeutic approaches to tackle cancer, fibrosis, and many age-related conditions have been uncovered by a team of scientists, including researchers from UCL.
Nov 29, 2023
0
18
Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to ...
Nov 28, 2023
0
1
